Ephicacy Consulting Group Acquires Advance Research Associates

Great Point Partners Makes Growth Investment in Ephicacy Consulting Group

July 21, 2022

Healthcare Services

Great Point Partners completed a growth investment in Ephicacy Consulting Group, a biometrics contract research organization (CRO) that provides statistical programming, data management, and real-world evidence analytics. The minority growth capital partnership will support Ephicacy's accelerated growth across its operations in the United States, Canada, and India and expand its clinical analytics capabilities.

Inhance Technologies Acquires Advance Research Chemicals

October 14, 2021

Manufacturing

Inhance Technologies, a portfolio company of Aurora Capital Partners, has completed the acquisition of Advance Research Chemicals (ARC), a specialty chemicals and materials producer with production facilities in the United States and Mexico. The add-on expands Inhance's capabilities in high-purity specialty chemicals, custom synthesis and private-label manufacturing to serve end markets including medical batteries, semiconductors, 3D printing and pharmaceuticals.

Avance Clinical Acquires C3 Research Associates to Expand into North America

September 6, 2022

Healthcare Services

Avance Clinical, a PE-backed Australian CRO, has acquired North American CRO partner C3 Research Associates to expand its later‑phase clinical trial capabilities and establish a US presence. Backed by private equity firm The Riverside Company, Avance will integrate C3 into its GlobalReady model and invest in growing its North American team to support biotechs transitioning from early‑phase studies in Australia/New Zealand to later phases in the US.

American Clinical Research Services Acquires Elixia

May 8, 2024

Healthcare Services

American Clinical Research Services (ACRS), a clinical research platform formed by Latticework Capital Management, has acquired Elixia, a multi-specialty clinical research site network operating in Florida, Massachusetts, Michigan and Missouri. The acquisition expands ACRS's footprint and capabilities in complex therapeutic areas—notably nephrology, neuroscience and infectious diseases—and adds Elixia's 40-bed Phase I unit in Tampa to ACRS's national site network.

ADVI Health Acquires Partnership for Health Analytic Research (PHAR)

August 23, 2024

Healthcare Services

ADVI Health has acquired Partnership for Health Analytic Research (PHAR), a global HTA and HEOR consultancy with roughly 20 years of experience delivering real-world evidence, patient registries, and value strategy research for biopharma clients. The acquisition expands ADVI’s Strategic Analytics, Value and Economics (SAVEs) capabilities—bringing PHAR’s HEOR and implementation science expertise into ADVI’s market access and commercialization services.

Evestia Clinical Merges with Atlantic Research Group

July 15, 2025

Healthcare Services

Kester Capital-backed Evestia Clinical has merged with US-based Atlantic Research Group (ARG) to create a larger independent specialist CRO with dual headquarters in Letchworth, UK and Charlottesville, VA. The combination expands Evestia's US footprint and adds neurology and late-stage clinical trial capabilities while broadening therapeutic expertise across oncology, rare diseases, immunology and inflammation.